patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
vandetanib
Marketedupdated 2mo agoby Genzyme Corp
Approvedcommunity read0 votes
all catalysts(19)
approval · 19
Apr 6, 2011
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 22, 2011
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Oct 9, 2012
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jul 3, 2013
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Nov 27, 2013
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Mar 31, 2014
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jul 28, 2016
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Feb 24, 2017
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
May 16, 2017
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Oct 12, 2018
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 5, 2020
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 15, 2020
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Mar 28, 2022
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Apr 13, 2023
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Mar 7, 2024
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
May 14, 2025
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 26, 2025
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Sep 23, 2025
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jan 27, 2026
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that